Decision guide
Longevity clinic is a marketing term, not a regulated category. In the United States there is no residency program or board certification in longevity medicine, so the label alone tells you nothing about the care behind it. The strongest signal of quality is not the length of the test menu. It is the quality of the decisions around testing: who selects it, who interprets it, what happens when something is found, and how the plan changes over time.
Because no external body certifies what a longevity clinic must be, the burden of evaluation falls on you. Three structural questions do most of the work. First, is a named, licensed physician clinically responsible for your care, and is that physician licensed or otherwise authorized to practice in the state where you will receive it? Every U.S. state medical board offers a free public license lookup, and a serious practice will volunteer the name rather than make you ask twice. Second, how does the clinic decide what to test and what not to test? Third, what happens after the report: who interprets, who follows up, and who coordinates with the rest of your medical life?
Multi-state care adds one more check. Telehealth visits are generally governed by the state where you are located at the time of the visit, so a practice serving members across states should be able to explain plainly how licensure is handled and confirm eligibility before enrollment, not after payment.
Broad, untargeted testing has a known failure mode: the more you measure in a healthy person, the more likely you are to find something that looks abnormal and means nothing, yet still demands time, money, and worry to resolve. When Dr. Brian Rank criticized executive physicals in the New England Journal of Medicine in 2008, this was the core of his argument: concentrating untargeted testing on the healthiest people inverts prevention priorities and generates incidental findings that trigger cascades of follow-up.
The lesson is not that diagnostic depth is bad. Advanced testing can be genuinely valuable when it answers a defined clinical question. The lesson is that depth without selection and follow-through produces anxiety and expense faster than it produces better decisions. Ask any clinic you are evaluating to explain, for two or three tests on its menu, which question each answers and what decision could change as a result.
If the experience ends when the report is delivered, you have purchased information, not care. You are left to interpret findings, decide what to act on, and coordinate follow-up alone, which is the exact problem most people came in with.
Continuity looks concrete when it is real: a scheduled reassessment rhythm, results compared against your own prior values rather than population averages alone, a plan that gets adjusted when your life or data change, and a person you can reach between appointments. Ask what happens in month seven of the relationship. The quality of that answer predicts the experience better than anything in the welcome brochure.
We publish our answers so you can compare them directly. Clinical leadership is provided by Dr. Frank Lipman, Chief Medical Officer, and medical care is provided by physicians licensed in the state where you are located, with eligibility confirmed before enrollment. Testing is selected by the medical team for a clinical purpose rather than sold from a menu, and Continuum, Core, and Elite each pair diagnostics with interpretation and a year of follow-through. Starting prices are published, and final scope is confirmed during a private orientation.
Direct answers
No. There is no U.S. residency program or board certification in longevity medicine, and the term is not regulated. Care quality depends on the licensed physicians behind a practice and the structure of the care, which is why verifying the responsible physician and their license matters more than the label.
Confirm that a named, licensed physician is clinically responsible for your care, verify the license through the state medical board's public lookup, and ask what happens after an abnormal or uncertain result. A clinic that cannot answer those three questions clearly is selling tests, not care.